149 related articles for article (PubMed ID: 19010528)
21. The calcium silicate/alginate composite: preparation and evaluation of its behavior as bioactive injectable hydrogels.
Han Y; Zeng Q; Li H; Chang J
Acta Biomater; 2013 Nov; 9(11):9107-17. PubMed ID: 23796407
[TBL] [Abstract][Full Text] [Related]
22. Behavior of encapsulated MG-63 cells in RGD and gelatine-modified alginate hydrogels.
Grigore A; Sarker B; Fabry B; Boccaccini AR; Detsch R
Tissue Eng Part A; 2014 Aug; 20(15-16):2140-50. PubMed ID: 24813329
[TBL] [Abstract][Full Text] [Related]
23. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
24. Alginate type and RGD density control myoblast phenotype.
Rowley JA; Mooney DJ
J Biomed Mater Res; 2002 May; 60(2):217-23. PubMed ID: 11857427
[TBL] [Abstract][Full Text] [Related]
25. Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel.
Panda NC; Zuckerman ST; Mesubi OO; Rosenbaum DS; Penn MS; Donahue JK; Alsberg E; Laurita KR
J Interv Card Electrophysiol; 2014 Nov; 41(2):117-27. PubMed ID: 25234602
[TBL] [Abstract][Full Text] [Related]
26. Transplantation of Epigenetically Modified Adult Cardiac c-Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model.
Zakharova L; Nural-Guvener H; Feehery L; Popovic-Sljukic S; Gaballa MA
Stem Cells Transl Med; 2015 Sep; 4(9):1086-96. PubMed ID: 26240433
[TBL] [Abstract][Full Text] [Related]
27. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction.
Hao X; Silva EA; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Wärdell E; Brodin LA; Mooney DJ; Sylvén C
Cardiovasc Res; 2007 Jul; 75(1):178-85. PubMed ID: 17481597
[TBL] [Abstract][Full Text] [Related]
28. Effect of TiO2 scaffolds coated with alginate hydrogel containing a proline-rich peptide on osteoblast growth and differentiation in vitro.
Rubert M; Pullisaar H; Gómez-Florit M; Ramis JM; Tiainen H; Haugen HJ; Lyngstadaas SP; Monjo M
J Biomed Mater Res A; 2013 Jun; 101(6):1768-77. PubMed ID: 23197406
[TBL] [Abstract][Full Text] [Related]
29. Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin-mediated toxicity.
Liu TC; Ismail S; Brennan O; Hastings C; Duffy GP
J Tissue Eng Regen Med; 2013 Apr; 7(4):302-11. PubMed ID: 22213742
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of coating alginate microcapsules with macromolecular heparin conjugates-in vitro and in vivo study.
Vaithilingam V; Kollarikova G; Qi M; Larsson R; Lacik I; Formo K; Marchese E; Oberholzer J; Guillemin GJ; Tuch BE
Tissue Eng Part A; 2014 Jan; 20(1-2):324-34. PubMed ID: 23971677
[TBL] [Abstract][Full Text] [Related]
31. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study.
Frey N; Linke A; Süselbeck T; Müller-Ehmsen J; Vermeersch P; Schoors D; Rosenberg M; Bea F; Tuvia S; Leor J
Circ Cardiovasc Interv; 2014 Dec; 7(6):806-12. PubMed ID: 25351198
[TBL] [Abstract][Full Text] [Related]
32. Soft-tissue augmentation with injectable alginate and syngeneic fibroblasts.
Marler JJ; Guha A; Rowley J; Koka R; Mooney D; Upton J; Vacanti JP
Plast Reconstr Surg; 2000 May; 105(6):2049-58. PubMed ID: 10839402
[TBL] [Abstract][Full Text] [Related]
33. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.
Wei HJ; Yang HH; Chen CH; Lin WW; Chen SC; Lai PH; Chang Y; Sung HW
J Control Release; 2007 Jul; 120(1-2):27-34. PubMed ID: 17532519
[TBL] [Abstract][Full Text] [Related]
34. Repeated low-dose of erythropoietin is associated with improved left ventricular function in rat acute myocardial infarction model.
Ben-Dor I; Hardy B; Fuchs S; Kaganovsky E; Kadmon E; Sagie A; Coleman R; Mansur M; Politi B; Fraser A; Harell D; Okon E; Battler A; Haim M
Cardiovasc Drugs Ther; 2007 Oct; 21(5):339-46. PubMed ID: 17912622
[TBL] [Abstract][Full Text] [Related]
35. Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction.
Merx MW; Zernecke A; Liehn EA; Schuh A; Skobel E; Butzbach B; Hanrath P; Weber C
Basic Res Cardiol; 2005 May; 100(3):208-16. PubMed ID: 15690102
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of chitosan-alginate-hyaluronate complexes modified by an RGD-containing protein as tissue-engineering scaffolds for cartilage regeneration.
Hsu SH; Whu SW; Hsieh SC; Tsai CL; Chen DC; Tan TS
Artif Organs; 2004 Aug; 28(8):693-703. PubMed ID: 15270950
[TBL] [Abstract][Full Text] [Related]
37. Biological activity of laminin peptide-conjugated alginate and chitosan matrices.
Yamada Y; Hozumi K; Katagiri F; Kikkawa Y; Nomizu M
Biopolymers; 2010; 94(6):711-20. PubMed ID: 20564024
[TBL] [Abstract][Full Text] [Related]
38. Fabrication of individual alginate-TCP scaffolds for bone tissue engineering by means of powder printing.
Castilho M; Rodrigues J; Pires I; Gouveia B; Pereira M; Moseke C; Groll J; Ewald A; Vorndran E
Biofabrication; 2015 Jan; 7(1):015004. PubMed ID: 25562119
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
Xu K; George I; Klotz S; Hay I; Xydas S; Zhang G; Cerami A; Wang J
J Cardiovasc Pharmacol; 2010 Nov; 56(5):506-12. PubMed ID: 20881614
[TBL] [Abstract][Full Text] [Related]
40. Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model.
Binsalamah ZM; Paul A; Khan AA; Prakash S; Shum-Tim D
Int J Nanomedicine; 2011; 6():2667-78. PubMed ID: 22114497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
